Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Cobo Marc | Principal Accounting Officer | 9 | $0 | $0 | 2026-10-21 |
| Elmelech Idan | COO & Principal Financial Ofcr | 3 | $0 | $0 | 2026-10-01 |
| Beltran Pedro | President and CEO, Director | 7 | $0 | $0 | 2026-10-01 |
| Ben Yong | Chief Med & Dev Officer | 6 | $0 | $0 | 2026-10-01 |
| Chen Bihua | Director, 10% Owner | 15 | $0 | $0 | 2026-07-01 |
| Lebowitz Peter F | Director | 2 | $0 | $0 | 2026-06-16 |
| Kelleher Raymond J. | Director | 1 | $0 | $0 | 2026-06-16 |
| Tipirneni Praveen P. | Director | 2 | $0 | $0 | 2026-06-16 |
| Kumar Neil | Director | 1 | $0 | $0 | 2026-06-16 |
| Bauer Jake | Director | 2 | $0 | $0 | 2026-06-16 |
| MCCORMICK FRANK | Director | 2 | $0 | $0 | 2026-06-16 |
| Mehra Uneek | Other | 4 | $0 | $0 | 2026-04-01 |
| Wallace Eli M. | Chief Executive Officer | 4 | $0 | $0 | 2026-01-01 |
| BridgeBio Pharma, Inc. | 10% Owner | 1 | $0 | $0 | 2025-10-10 |
| Holman Albert A III | Other | 2 | $0 | $0 | 2025-08-11 |
| McKenna Mark C. | Other | 2 | $0 | $0 | 2025-08-11 |
| Schmid John P. | Other | 2 | $0 | $0 | 2025-08-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Cobo Marc | Principal Accounting Officer | F Tax w/h | 2026-10-21 | 2026-10-23 | 203 | $2.68 | $544 | 13,812 | SEC↗ |
| Cobo Marc | Principal Accounting Officer | F Tax w/h | 2026-10-01 | 2026-10-05 | 126 | $3.94 | $496 | 14,015 | SEC↗ |
| Elmelech Idan | COO & Principal Financial Of | F Tax w/h | 2026-10-01 | 2026-10-05 | 343 | $3.94 | $1.4K | 14,152 | SEC↗ |
| Ben Yong | Chief Med & Dev Officer | F Tax w/h | 2026-10-01 | 2026-10-05 | 1,047 | $3.94 | $4.1K | 43,529 | SEC↗ |
| Beltran Pedro | President and CEO, Director | F Tax w/h | 2026-10-01 | 2026-10-05 | 1,047 | $3.94 | $4.1K | 43,529 | SEC↗ |
| Cobo Marc | Principal Accounting Officer | A Award deriv | 2026-09-10 | 2026-09-14 | 43,700 | — | $0 | 43,700 | SEC↗ |
| Cobo Marc | Principal Accounting Officer | F Tax w/h | 2026-09-10 | 2026-09-14 | 203 | $5.52 | $1.1K | 14,141 | SEC↗ |
| Cobo Marc | Principal Accounting Officer | A Award | 2026-09-10 | 2026-09-14 | 9,038 | — | $0 | 14,344 | SEC↗ |
| Cobo Marc | Principal Accounting Officer | A Award deriv | 2026-09-10 | 2026-09-14 | 43,700 | — | $0 | 43,700 | SEC↗ |
| Cobo Marc | Principal Accounting Officer | F Tax w/h | 2026-09-10 | 2026-09-14 | 203 | $5.52 | $1.1K | 14,141 | SEC↗ |
| Cobo Marc | Principal Accounting Officer | A Award | 2026-09-10 | 2026-09-14 | 9,038 | — | $0 | 14,344 | SEC↗ |
| Chen Bihua | Director, 10% Owner | J Other | 2026-07-01 | 2026-07-06 | 4,528,186 | — | $0 | 0 | SEC↗ |
| Chen Bihua | Director, 10% Owner | J Other | 2026-07-01 | 2026-07-06 | 2,692,459 | — | $0 | 4,879,995 | SEC↗ |
| Chen Bihua | Director, 10% Owner | J Other | 2026-07-01 | 2026-07-06 | 1,704,862 | — | $0 | 5,010,332 | SEC↗ |
| Chen Bihua | Director, 10% Owner | J Other | 2026-07-01 | 2026-07-06 | 130,865 | — | $0 | 6,083,221 | SEC↗ |
| Beltran Pedro | President and CEO | F Tax w/h | 2026-07-01 | 2026-07-06 | 1,047 | $7.80 | $8.2K | 44,576 | SEC↗ |
| Ben Yong | Chief Med & Dev Officer | F Tax w/h | 2026-07-01 | 2026-07-06 | 1,047 | $7.80 | $8.2K | 44,576 | SEC↗ |
| Elmelech Idan | COO & Principal Financial Of | F Tax w/h | 2026-07-01 | 2026-07-06 | 343 | $7.80 | $2.7K | 14,495 | SEC↗ |
| Cobo Marc | Principal Accounting Officer | F Tax w/h | 2026-07-01 | 2026-07-06 | 125 | $7.80 | $975 | 5,306 | SEC↗ |
| Kumar Neil | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 31,675 | — | $0 | 31,675 | SEC↗ |
| Bauer Jake | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 31,675 | — | $0 | 31,675 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award deriv | 2026-06-16 | 2026-06-18 | 31,675 | — | $0 | 31,675 | SEC↗ |
| Kelleher Raymond J. | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 31,675 | — | $0 | 31,675 | SEC↗ |
| Lebowitz Peter F | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 7,289 | — | $0 | 7,289 | SEC↗ |
| MCCORMICK FRANK | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 31,675 | — | $0 | 31,675 | SEC↗ |
| Tipirneni Praveen P. | Director | A Award deriv | 2026-06-16 | 2026-06-18 | 31,675 | — | $0 | 31,675 | SEC↗ |
| Beltran Pedro | President and CEO | A Award deriv | 2026-05-10 | 2026-05-12 | 1,103,837 | — | $0 | 1,103,837 | SEC↗ |
| Elmelech Idan | COO & Principal Financial Of | A Award deriv | 2026-05-10 | 2026-05-12 | 758,222 | — | $0 | 758,222 | SEC↗ |
| Mehra Uneek | Other | F Tax w/h | 2026-04-01 | 2026-05-05 | 524 | $9.03 | $4.7K | 22,806 | SEC↗ |
| Beltran Pedro | President and CEO | F Tax w/h | 2026-04-01 | 2026-05-05 | 1,047 | $9.03 | $9.5K | 45,623 | SEC↗ |
| Ben Yong | Chief Med & Dev Officer | F Tax w/h | 2026-04-01 | 2026-05-05 | 1,047 | $9.03 | $9.5K | 45,623 | SEC↗ |
| Lebowitz Peter F | Director | A Award deriv | 2026-03-24 | 2026-03-26 | 63,350 | — | $0 | 63,350 | SEC↗ |
| Ben Yong | Chief Med & Dev Officer | A Award deriv | 2026-03-10 | 2026-03-12 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Beltran Pedro | Chief Scientific Officer | A Award deriv | 2026-03-10 | 2026-03-12 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Mehra Uneek | Chief Financial Officer | A Award deriv | 2026-03-10 | 2026-03-12 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Ben Yong | Chief Med & Dev Officer | A Award | 2026-03-10 | 2026-03-12 | 46,670 | — | $0 | 46,670 | SEC↗ |
| Beltran Pedro | Chief Scientific Officer | A Award | 2026-03-10 | 2026-03-12 | 46,670 | — | $0 | 46,670 | SEC↗ |
| Mehra Uneek | Chief Financial Officer | A Award | 2026-03-10 | 2026-03-12 | 23,330 | — | $0 | 23,330 | SEC↗ |
| Wallace Eli M. | Chief Executive Officer | A Award deriv | 2026-01-01 | 2026-01-05 | 1,114,400 | — | $0 | 1,114,400 | SEC↗ |
| Wallace Eli M. | Chief Executive Officer | D To issuer deriv | 2025-12-10 | 2025-12-12 | 1,114,400 | — | $0 | 500,000 | SEC↗ |
| BridgeBio Pharma, Inc. | 10% Owner | J Other | 2025-10-10 | 2025-10-16 | 784,720 | — | $0 | 14,589,846 | SEC↗ |
| Wallace Eli M. | Chief Executive Officer | A Award deriv | 2025-10-02 | 2025-10-06 | 1,614,400 | — | $0 | 1,614,400 | SEC↗ |
| Mehra Uneek | Chief Financial Officer | A Award deriv | 2025-08-26 | 2025-08-28 | 633,570 | — | $0 | 633,570 | SEC↗ |
| Wallace Eli M. | Chief Executive Officer | A Award deriv | 2025-08-26 | 2025-08-28 | 499,731 | — | $0 | 499,731 | SEC↗ |
| Ben Yong | Chief Med & Dev Officer | A Award deriv | 2025-08-26 | 2025-08-28 | 357,177 | — | $0 | 357,177 | SEC↗ |
| Beltran Pedro | Chief Scientific Officer | A Award deriv | 2025-08-26 | 2025-08-28 | 357,177 | — | $0 | 357,177 | SEC↗ |
| Bauer Jake | Director | A Award deriv | 2025-08-26 | 2025-08-28 | 138,193 | — | $0 | 138,193 | SEC↗ |
| MCCORMICK FRANK | Director | A Award deriv | 2025-08-26 | 2025-08-28 | 91,076 | — | $0 | 91,076 | SEC↗ |
| Tipirneni Praveen P. | Director | A Award deriv | 2025-08-26 | 2025-08-28 | 52,269 | — | $0 | 52,269 | SEC↗ |
| Schmid John P. | Other | M Exercise deriv | 2025-08-11 | 2025-08-11 | 30,000 | — | $0 | 0 | SEC↗ |
| McKenna Mark C. | Other | M Exercise deriv | 2025-08-11 | 2025-08-11 | 30,000 | — | $0 | 0 | SEC↗ |
| Holman Albert A III | Other | M Exercise deriv | 2025-08-11 | 2025-08-11 | 30,000 | — | $0 | 0 | SEC↗ |
| Chen Bihua | Director, 10% Owner | M Exercise deriv | 2025-08-11 | 2025-08-13 | 4,172,126 | — | $0 | 0 | SEC↗ |
| Chen Bihua | Director, 10% Owner | D To issuer deriv | 2025-08-11 | 2025-08-13 | 307,874 | — | $0 | 4,172,126 | SEC↗ |
| Schmid John P. | Other | M Exercise | 2025-08-11 | 2025-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| McKenna Mark C. | Other | M Exercise | 2025-08-11 | 2025-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Holman Albert A III | Other | M Exercise | 2025-08-11 | 2025-08-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award | 2025-08-11 | 2025-08-13 | 639,110 | $10.72 | $6.85M | 1,542,710 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award | 2025-08-11 | 2025-08-13 | 5,598,425 | $10.72 | $60.02M | 5,667,785 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award | 2025-08-11 | 2025-08-13 | 1,905,046 | — | $0 | 1,905,046 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award | 2025-08-11 | 2025-08-13 | 1,762,760 | — | $0 | 3,305,470 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award | 2025-08-11 | 2025-08-13 | 284,571 | — | $0 | 5,952,356 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award | 2025-08-11 | 2025-08-13 | 760,496 | $10.72 | $8.15M | 2,187,536 | SEC↗ |
| Chen Bihua | Director, 10% Owner | M Exercise | 2025-08-11 | 2025-08-13 | 4,172,126 | — | $0 | 4,681,126 | SEC↗ |
| Chen Bihua | Director, 10% Owner | D To issuer | 2025-08-11 | 2025-08-13 | 152,940 | — | $0 | 4,528,186 | SEC↗ |